Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|90|1|67-72

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.90, Iss.1, 2009-06, pp. : 67-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effective Treatment of Locally Advanced Endocrine Tumors of the Pancreas with Chemoradiotherapy

By  

Neuroendocrinology, Vol. 85, Iss. 4, 2007-05 ,pp. : 216-220

Karger

Access to resources Recommend Favorite

Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2013-01 ,pp. : 318-321

Karger

Access to resources Recommend Favorite

Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary

By  

Neuroendocrinology, Vol. 87, Iss. 1, 2007-11 ,pp. : 47-62

Karger

Access to resources Recommend Favorite

Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors

By  

Neuroendocrinology, Vol. 88, Iss. 1, 2008-02 ,pp. : 53-58

Karger

Access to resources Recommend Favorite

Endocrine Complications and Components of the Metabolic Syndrome in Survivors of Childhood Malignant Non-Brain Solid Tumors

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 1, 2013-11 ,pp. : 32-42

Karger

Access to resources Recommend Favorite